Health
FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014 | FDA – FDA.gov
FDA approves Wegovy (semaglutide) injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition.
For Immediate Release:
June 04, 2021
Today, the U.S. Food and Drug Administration approved Wegovy (semaglutide) injection (2.4 mg once weekly) for chronic weight management in adults with obesity or overweight with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol), for use in addition to a reduced calorie diet and increased physical activity. This under-the-skin injection is the first approved drug for chronic weight management in adults with…
-
Business23 hours agoForget CBA and buy these high-yield ASX dividend shares
-
Noosa News22 hours agoThe Almond Ashes sees Australia and India mix business and cricket
-
General22 hours agoUK PM ready to ‘shelter’ businesses from tariff storm
-
General22 hours agoWhy do states and territories have different school holidays?